{
    "Trade/Device Name(s)": [
        "CLUNGENE Multi-Drug Test Dip Card",
        "CLUNGENE Multi-Drug Test Easy Cup"
    ],
    "Submitter Information": "Hangzhou Clongene Biotech Co., Ltd.",
    "510(k) Number": "K181790",
    "Predicate Device Reference 510(k) Number(s)": [
        "K142396"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NGL",
        "NGG",
        "QAW",
        "NGM",
        "NFT",
        "NFW",
        "NFY",
        "NGG",
        "NGM",
        "NFV",
        "PTH",
        "PTG"
    ],
    "Summary Letter Date": "June 25, 2018",
    "Summary Letter Received Date": "July 5, 2018",
    "Submission Date": "July 25, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3100",
        "21 CFR 862.3870",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3170",
        "21 CFR 862.3150",
        "21 CFR 862.3620",
        "21 CFR 862.3910"
    ],
    "Regulation Name(s)": [
        "Opiate Test System",
        "Amphetamine Test System",
        "Cannabinoids Test System",
        "Cocaine Test System",
        "Methamphetamine Test System",
        "Benzodiazepine Test System",
        "Barbiturate Test System",
        "Methadone Test System",
        "Tricyclic Antidepressant Drugs Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Oxazepam",
        "Cocaine",
        "Marijuana",
        "Methamphetamine",
        "Morphine",
        "Oxycodone",
        "Secobarbital",
        "Methadone",
        "Buprenorphine",
        "Phencyclidine",
        "Methylenedioxymethamphetamine",
        "Tricyclic Antidepressants"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding immunoassay",
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Antigen-antibody immunochemistry",
        "Lateral flow",
        "Immunochromatography"
    ],
    "Submission Type(s)": [
        "Kit",
        "Device",
        "Cup",
        "Dip Card"
    ],
    "Document Summary": "FDA 510(k) summary for CLUNGENE Multi-Drug Test Dip Card and Easy Cup qualitative lateral flow immunoassays for simultaneous detection of multiple drugs of abuse in urine",
    "Indications for Use Summary": "Qualitative, simultaneous detection of amphetamine, oxazepam, cocaine, marijuana, methamphetamine, morphine, oxycodone, secobarbital, methadone, buprenorphine, phencyclidine, methylenedioxymethamphetamine and tricyclic antidepressants in human urine for preliminary results, not distinguishing prescription use or abuse; positive results require confirmatory testing",
    "fda_folder": "Toxicology"
}